v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

PREVALENCE AND COMPLICATION OF CELIAC DISEASE AMONG SAUDI CHILDREN: A CROSS-SECTIONAL STUDY

AUTHORS:

Mariam Mohammed Alrsheedy , Hoda Jehad Abousada , Yasmen Taha Maimani , Nouf Abdulkhaliq Almehmadi , Nada Mohammed Alshanqiti , Faisal Fahad Alnazawi , Ghadah Abdulrahman Albalawi , Abdulrahman Ibrahim Alwakil , Samera Hanash Alamri , Hatun Sulaiman ALSurayhi , Elaf Abdulkader Kanoori , Abdulellah Talal Alhazmi , Reem Ibrahim Almuashi , Ghaidaa Faisal Albaz

ABSTRACT:

Introduction: Celiac disease (CD) is a chronic and autoimmune disorder caused by inflammatory T-cells response to the gluten-containing proteins. This disease may be expressed due to genetic predisposition, an autoimmune disorder, or environmental factors. Methodology: This is a cross-sectional study that included only the pediatric population and aimed to determine the prevalence and complications of CD among children. A predesigned self-administered questionnaire was constructed by the researcher; it covered the socio-demographic data, the patients’ clinical data, including their state, the possible complications of the disease, and the diabetic patients. Results: A total of 729 children were included, 63.1% were females, and the ones aging above ten years ranked with 31.7%. The prevalence of CD was 32.4%, and only 11.2% were diabetic. More than half of this population did not suffer any complications at all (54.7%), while malnutrition and bone weakening were the most common complications with (27.8%) and (15.5%), respectively. Conclusion: There is a relatively low prevalence of CD among children. The majority of our population did not suffer any complications. Furthermore, malnutrition and bone weakening constituted the most frequent complications among the patients.

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.